Author:
Friesen Inna,Saluzzo Francesca,Groenheit Ramona,Aubry Alexandra,Anthony Richard,Niemann Stefan,Mathys Vanessa,Cirillo Daniela Maria,Indra Alexander,Mathys Vanessa,Atanasova Yuliana,Obrovac Mihaela,Žmak Ljiljiana,Pieridou Despo,Dvořákov Věra,Troels Lillebæk ,Kummik Tiina,Klaos Kadri,Soini Hanna,Haanperä-Heikkinen Marjo,Mentula Silja,Jérôme Robert,Cambau Emmanuelle,Niemann Stefan,Panayotis Ioannidis,Papaventsis Dimitrios,Bakos Ágnes,Szél Viktória,Lőrinczi Lilla Katalin,Fitzgibbon Margaret,Boyle Breida,Cirillo Daniela Maria,Giannoni Federico,Pole Ilva,Norvaiša Inga,Vasiliauskaite Laima,Perrin Monique,Deguara Catriona,Anthony Richard,Mengshoel Anne Torunn,Augustynowicz-Kopeć Ewa,Macedo Rita,Coriu Roxana Mihaela,Porvaznik Igor,Klemen Špela,Herrera-León Laura,Groenheit Ramona,Werngren Jim
Reference6 articles.
1. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update,2023
2. A 24-week, all-oral regimen for rifampin-resistant tuberculosis;Nyang’wa;New Engl J Med,2022
3. Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe;Günther;Clin Microbiol Infect,2024
4. Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis;Sonnenkalb;Lancet Microbe,2023
5. WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection,2024